AzTrials
AzTrials

Prehospital ResuscitationNCT07632430

End-Tidal CO2 (ETCO2) Trends in Out-of-Hospital Cardiac Arrest

An observational study of Prehospital Resuscitation and End-Tidal Carbon Dioxide, run by Office of the Medical Director for EMS in Oklahoma City and Tulsa at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The investigators aim to assess the relationship between patient characteristics, prehospital treatments, and vital signs to determine if a threshold EtCO2 value, a change in EtCO2 value (final - initial), or a trend in EtCO2 (positive/negative) is a better predictor of patient survival to discharge. Read more about this study

Who is it for?
Ages 18 years and older
How many people
3,500 participants
Where
1 siteUnited States
Study dates
1 Jan 2024to 30 Sep 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This is a retrospective cohort study. All patients encountered by emergency medical services in Oklahoma City and Tulsa experiencing an out-of-hospital cardiac arrest from Jan 1, 2024, to July 1, 2025, will be evaluated against the inclusion and exclusion criteria.

Who may be able to join

  • EHR's resulting from 9-1-1 response
  • Adult patients (aged 18+ at time of cardiac event)
  • experiencing out-of-hospital cardiac arrest (OHCA)
  • transported by an agency under OMD oversight
  • must have at least 2 EtCO2 values captured during care Exclusion Criteria
  • EHR's resulting from inter-facility scheduled or unscheduled medical transfers
Show all 9Show fewer
  • pediatric patients (those aged <18 at time of incident) or unknown age
  • ROSC obtained prior to arrival of EMS
  • insufficient vital sign data

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Office of the Medical Director of EMS for Metropolitan Oklahoma City and Tulsa

    Oklahoma City, Oklahoma, 73135

Other trials in United States

About this study

The investigators aim to assess the relationship between patient characteristics, prehospital treatments, and vital signs to determine if a threshold EtCO2 value, a change in EtCO2 value (final - initial), or a trend in EtCO2 (positive/negative) is a better predictor of patient survival to discharge. The secondary aim of this project is to identify significant predictors of neurologically intact patient survival as indicated by a cerebral performance category (CPC) score of 1-2.

Medical subject headings
Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07632430
Study groupRoleWhat they receive
stable ETCO2low variation in measured end-tidal CO2 during cpr; low/high threshold yet to be determined
unstable/trending ETCO2variability in end-tidal CO2 during CPR, with or without measurable trend

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival to Hospital Discharge

    lack of terminiation of CPR during prehospital or in hospital care

    Measured: 90 days

Secondary outcomes (1)
  1. Neurologically Intact Patient Survival

    Based on Gasgow-Pittsburgh Cerebral Performance Category (CPC) score which ranges from 1 (best) to 5 (worst). Neurologically intact is defined as a score of 1-2 among survivors

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2026
  2. Study start1 Jan 2024
  3. Primary completion1 Jul 2025
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
3,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07632430
Sponsor's protocol ID
ERP#14222
Other IDs
ERP#14222
Status last verified
Jun 2026
First submitted
2 Jun 2026
Last updated
9 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sun KF, Poon KM, Lui CT, Tsui KL. Clinical prediction rule of termination of resuscitation for out-of-hospital cardiac arrest patient with pre-hospital defibrillation given. Am J Emerg Med. 2021 Dec;50:733-738. doi: 10.1016/j.ajem.2021.09.058. Epub 2021 Sep 29.

    PubMed 34879495
  • Smida T, Menegazzi JJ, Crowe RP, Salcido DD, Bardes J, Myers B. The Association of Prehospital End-Tidal Carbon Dioxide with Survival Following Out-of-Hospital Cardiac Arrest. Prehosp Emerg Care. 2024;28(3):478-484. doi: 10.1080/10903127.2023.2262566. Epub 2023 Oct 6.

    PubMed 37751228
  • Richardson M, Moulton K, Rabb D, Kindopp S, Pishe T, Yan C, Akpinar I, Tsoi B, Chuck A. Capnography for Monitoring End-Tidal CO2 in Hospital and Pre-hospital Settings: A Health Technology Assessment [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Mar. Available from http://www.ncbi.nlm.nih.gov/books/NBK362374/

    PubMed 27227208
  • Kudu E, Danis F, Karaca MA, Erbil B. Usability of EtCO2 values in the decision to terminate resuscitation by integrating them into the TOR rule (an extended TOR rule): A preliminary analysis. Heliyon. 2023 Sep 13;9(9):e19982. doi: 10.1016/j.heliyon.2023.e19982. eCollection 2023 Sep.

    PubMed 37809508
  • Hatlestad D. Capnography as a predictor of the return of spontaneous circulation. Emerg Med Serv. 2004 Aug;33(8):75-80; quiz 115.

    PubMed 15368978
  • Hambelton C, Wu L, Smith J, Thompson K, Neth MR, Daya MR, Jui J, Lupton JR. Utility of end-tidal carbon dioxide to guide resuscitation termination in prolonged out-of-hospital cardiac arrest. Am J Emerg Med. 2024 Mar;77:77-80. doi: 10.1016/j.ajem.2023.11.030. Epub 2023 Dec 7.

    PubMed 38104387
  • Eckstein M, Hatch L, Malleck J, McClung C, Henderson SO. End-tidal CO2 as a predictor of survival in out-of-hospital cardiac arrest. Prehosp Disaster Med. 2011 Jun;26(3):148-50. doi: 10.1017/S1049023X11006376.

    PubMed 22107764
  • Dudaryk R, Bodzin DK, Ray JJ, Jabaley CS, McNeer RR, Epstein RH. Low End-Tidal Carbon Dioxide at the Onset of Emergent Trauma Surgery Is Associated With Nonsurvival: A Case Series. Anesth Analg. 2017 Oct;125(4):1261-1266. doi: 10.1213/ANE.0000000000002283.

    PubMed 28704248

Questions about this trial

What is this clinical trial studying?

An observational study of Prehospital Resuscitation and End-Tidal Carbon Dioxide, run by Office of the Medical Director for EMS in Oklahoma City and Tulsa at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 9 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival to Hospital Discharge (time frame: 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07632430, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in